Organizers claimed that nearly 2 million Hong Kong protesters took to the streets Sunday in a rally to demand the city's top official resign a day after she suspended — but...China Politicsread more
Heavy rains caused unprecedented delays in planting this year and contributed to record floods across the central United States.Agricultureread more
Stocks in Asia traded mixed on Monday as investors await a U.S. Federal Reserve meeting set to happen later in the week stateside.Asia Marketsread more
Although Cook did not mention companies by name, his commencement speech in Silicon Valley's backyard mentioned data breaches, privacy violations, and even made reference to...Technologyread more
In the survey, 66% of Democratic primary voters say they'd be enthusiastic or comfortable about Biden as their nominee to take on President Trump in the 2020 election. Just...Politicsread more
U.S. ambassador to Israel David Friedman called the gesture a "birthday present" to Trump, who turned 73 on Friday.Politicsread more
The outlook for Germany's economy and political stability are more uncertain than ever, writes Michael Ivanovitch.World Economyread more
Hong Kong democracy activist Joshua Wong walked free from prison on Monday after serving nearly five weeks for contempt of court, pledging to join a mass protest movement...China Politicsread more
The agreement, which is on the framework for the plan of adjustment, provide for more than a 60% average haircut for all $35 billion, a 36% haircut on pre-2012 general...Bondsread more
Target's registers were down on Saturday for several hours preventing customers from checking out.Retailread more
The newspaper wrote that Goldman's executive are hoping CEO David Solomon's changes to a firm that historically thrived in investment banking and trading will boost its...US Marketsread more
Sales of shingles vaccines boosted GlaxoSmithKline's profits in the final quarter of 2018, allaying investor concerns about Britain's biggest drugmaker's prospects beyond its blockbuster Advair asthma drug.
However, the drugmaker cautioned that full-year earnings for 2019 would decline between 5 percent and 9 percent because of fresh competition for Advair from Mylan's generic treatment, which won approval from U.S. regulators last month, and the impact of its $5.1 billion Tesaro acquisition.
Sales of Shingrix, the company's Shingles vaccine launched in 2017, more than doubled in the quarter to 221 million pounds, while Advair sales fell 20 percent to 647 million pounds, although that was still more than the 592 million pounds expected by analysts.
GSK shares reversed earlier losses to trade marginally higher at 1527.6 pence by 1 p.m. GMT.
GSK has been streamlining operations and spinning off or selling units, including its consumer health division, in order to focus on expanding its drug pipeline and developing vaccines.
The moves come as British companies face the many unknowns related to the UK's impending exit the European Union.
GSK, which is heavily dependent on international markets, said that there was "considerable uncertainty" about Brexit and warned that leaving the bloc without a exit deal would be a bad outcome.
Britain is due to leave the EU on March 29, and with Prime Minister Theresa May still battling to get parliamentary approval for her exit plan, businesses are spending millions of pounds to prepare for a "no-deal" exit.
GSK reported adjusted earnings per share of 31.2 pence on sales of about 8.20 billion pounds ($10.62 billion) in the three months to Dec. 31.
Analysts had expected earnings of 27.7 pence and sales of 7.95 billion pounds, according to a company-provided consensus of 11 analysts.
Brokerage Jefferies said it believed the initial 2019 earnings target of between 5 percent and 9 percent lower should be well received, given widespread concern of up to a double-digit decline.